 |
June 17, 2026Barcelona, Spain /PRNewswire/ — Skin Tech Pharma Group proudly announces that its flagship product, RRS® HA LONG LASTING, has been awarded the Best Injectable Product in Skin Rejuvenation at the 2026 AMWC World Congress on Aesthetic Medicine & Anti-Aging Awards. This accolade is a highly prestigious honor in the field of aesthetic medicine.
RRS® HA Long Lasting by Skin Tech Pharma Group
Since its launch in 2021, RRS® HA LONG LASTING has become a benchmark innovation in the emerging Skin Builder category. With over 1 million clinical applications worldwide, the product has demonstrated robust safety and exceptional clinical efficacy, combining skin quality improvement with natural rejuvenation, redefining aesthetic treatment protocols.
This award not only recognizes the product’s contribution to advancing regenerative aesthetic medicine but also underscores the growing market demand: consumers increasingly prefer aesthetic solutions that deliver natural results while maintaining long-term skin health and tissue condition, supporting graceful anti-aging.
Márcio Rodrigues, CEO of Skin Tech Pharma Group, stated:
“Receiving this award is a significant milestone for us and validates the value of our long-term strategic development. As the aesthetic medicine market landscape continues to evolve, our goal is to lead the industry through rigorous scientific rigor, differentiated innovation, and a deep understanding of medical professionals’ needs. This recognition highlights our commitment to achieving sustainable growth while elevating treatment standards across the industry.”
About RRS® HA Long Lasting — The Skin Builder Flagship
RRS® HA Long Lasting is neither a traditional mesotherapy product nor a dermal filler; it combines the core advantages of both in a single product.
RRS® HA Long Lasting is a Skin Builder product containing cross-linked hyaluronic acid and a protective buffer system composed of 15 amino acids. It strengthens the dermal structure, enhances skin hydration, firmness, and texture, while providing gentle lifting and improving various wrinkles and fine lines. The product delivers immediate, natural results with progressive skin improvement, backed by extensive clinical safety data. It is the first Skin Builder product with a dual mechanism of action, offering a comprehensive solution to combat skin aging by simultaneously improving skin quality and naturally restoring facial volume.
Thanks to its advanced technology, the product progressively improves skin quality, leading to increasingly healthier skin. Patients see immediate results after treatment, with continued improvement over subsequent weeks, culminating in a natural appearance and high user satisfaction. For more information, please visit:
Dr. Javed Hussain, an industry authority invited by Skin Tech Pharma Group, noted: “Clinical applications show that this product sustainably improves skin texture, elasticity, and overall radiance. This Skin Builder product, with its core formula of hyaluronic acid combined with an amino acid protective buffer solution, provides essential nutrients to restore the skin’s native functions that decline with age. In practice, its results are consistent and reliable, safety meets industry standards, and the duration of efficacy far exceeds traditional mesotherapy products.”
About Skin Tech Pharma Group: “30 Years of Innovation”
Skin Tech Pharma Group S.L.U. is a global leader in the aesthetic medicine industry, specializing in high-standard EU CE-certified medical devices and premium cosmeceuticals. Founded in 1994 by Dr. Philippe Deprez, the company is headquartered on the Costa Brava, Spain, and is wholly owned by Charterhouse Capital Partners and EXCELSIS. The launch of Easy TCA® in 1996 established the company as an industry pioneer. Today, after three decades of innovation, the group operates state-of-the-art in-house laboratories and a global R&D team. The company develops aesthetic products to pharmaceutical-grade standards, providing trusted, evidence-based solutions worldwide. For more information, please visit: https://www.skintechpharmagroup.com/
RRS® HA Long Lasting awarded as Best Injectable by AMWC 2026.